We are live on ! Find out more
GPP

Great Point Partners Portfolio holdings

AUM $435M
1-Year Est. Return 318.81%
This Fund
S&P 500
This Quarter Est. Return
+49.72%
1 Year Est. Return
+318.81%
3 Year Est. Return
+553.97%
5 Year Est. Return
+856.21%
10 Year Est. Return
+18,148.08%
AUM
$144M
AUM Growth
–
Cap. Flow
+$122M
Cap. Flow %
84.64%
Top 10 Hldgs %
70.1%
Holding
32
New
31
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$20.6M
2
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$14.5M
3
AMBI
Ambit Biosciences Corp
AMBI
+$11.7M
4
FLNA
Filana Therapeutics
FLNA
+$7.27M
5
NSPH
NANOSPHERE INC. COM NEW
NSPH
+$6.24M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 42.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNR
26
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$846K 0.59%
+200,000
New +$948K
PTX
27
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$807K 0.56%
+29,681
New +$955K
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$335K 0.23%
+100,000
New +$264K
ALIM
29
CALL
DELISTED
Alimera Sciences
ALIM
$279K 0.19%
+4,953
New +$311K
PTN
30
Palatin Technologies
PTN
$13.7M
$133K 0.09%
+154
New +$128K
ONCT
31
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$117K 0.08%
+41
New +$204K
1
2

Similar funds

GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
SWG
Summit Wealth Group White River Junction, Vermont $436M AUM 13.96% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return
VIM
VELA Investment Management New Albany, Ohio $436M AUM 15.16% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Great Point Partners's Q3 2013 Portfolio in Review

Q3 2013 is the first quarter with a 13F filing on record for Great Point Partners, which disclosed 32 positions worth $144M. Its ten largest holdings account for 70% of the portfolio.

Its largest position is HYPERION THERAPEUTICS INC COM STK (DE): 820,906 shares worth $21.4M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets.

  • Great Point Partners's largest Q3 2013 buy was HYPERION THERAPEUTICS INC COM STK (DE): 820,906 shares worth $21.4M.
  • Great Point Partners's ten largest holdings make up 70% of its $144M portfolio in Q3 2013.
  • Great Point Partners disclosed 32 positions in Q3 2013, its first 13F filing on record.

Based on Great Point Partners's 13F filing for Q3 2013, filed 14 Nov 2013.